HAIFA, Israel--(BUSINESS WIRE)--Pluristem Life Systems, Inc. (OTCBB: PLRS), a cell therapy company
dedicated to the commercialization of stem cell products, announces
promising final...
HAIFA, Israel--(BUSINESS WIRE)--Sept. 12, 2006--Pluristem Life Systems, Inc. (OTCBB: PLRS) announces they have been chosen to present at the 35th Annual Scientific Meeting of the International...
EL DORADO HILLS, Calif.--(BUSINESS WIRE)--Sept. 6, 2006--Dutton Associates initiates coverage of Pluristem Life Sciences (OTCBB:PLRS) with a neutral rating. The 13-page report by Dutton senior...
HAIFA, Israel--(BUSINESS WIRE)--Sept. 5, 2006--Pluristem Life Systems, Inc. (OTCBB:PLRS) announces CEO Zami Aberman will speak at the 2006 Biotech & Life Sciences Global Venture Congress being held...
HAIFA, Israel--(BUSINESS WIRE)--Aug. 24, 2006--Pluristem Life Systems, Inc. (OTCBB:PLRS) announces that its fully owned subsidiary Pluristem Ltd received a $470,000 grant from Israel's prestigious...
HAIFA, Israel--(BUSINESS WIRE)--July 5, 2006--Pluristem Life Systems, Inc. (OTCBB:PLRS), a cell therapy company dedicated to the commercialization of stem cell products, today announced promising...
HAIFA, Israel--(BUSINESS WIRE)--June 26, 2006--Pluristem Life Systems, Inc. (OTCBB:PLRS), a cell therapy company dedicated to the commercialization of stem cell products, announces it has engaged...
#10: PLRS News Pluristem Ignites Technological Innovation in the Selection and Separation of Hematopoetic Stem Cells from Cord Blood for Bone Marrow Transplantation
HAIFA, Isreal--(BUSINESS WIRE)--Dec. 7, 2005-- Company's Use of Non-Selected MonoNuclear Cells in PluriX(TM) Bioreactor Reaps Significant Results, Low Cell Loss Ratio, a Highly Cost-Effective...
HAIFA, Israel--(BUSINESS WIRE)--Nov. 9, 2005-- Pioneer and World-Acclaimed Leader in Field of Umbilical Cord Blood, Cord Blood Banking and Stem Cell Separation and Treatment, to Bring...
HAIFA, Israel--(BUSINESS WIRE)--Oct. 26, 2005--Please replace the release with the following corrected version due to multiple revisions. The corrected release reads: PLURISTEM APPOINTS DR. ORA...
HAIFA, Israel--(BUSINESS WIRE)--Oct. 6, 2005-- Company Simulates Natural Environment of Human Bone to Expand Hematopoietic Stem Cells, Without Growth Factors, Initially Targeting Bone Marrow...
HAIFA, Israel--(BUSINESS WIRE)--Sept. 27, 2005--Pluristem Life Systems, Inc. (OTC BB:PLRS), a biotechnology company dedicated to the expansion of stem cells from umbilical cord blood to address a...
Pluristem Obtains Notice of Allowance from U.S. Patent Office Providing Broad Coverage of Proprietary Stem Cell Expansion Technology
HAIFA, Israel
For Pluristem Life Systems, Inc.
DeMonte...
Pluristem Completes $3.2 Million Interim Private Placement
HAIFA, Israel
For Pluristem Life Systems, Inc.
DeMonte Associates
Cynthia DeMonte, 212-605-0525
cdemonte@aol.com
Working Capital...